Table 2.
Relative Efficacy and Relative Side Effect Profiles of Pharmacologic Treatment Options for Opioid Use Disorder76-81
Drug Class | Drug | Relative Efficacy | Relative Side Effect Profile | Abuse Potential | Respiratory Depression Risk | Arrhythmia Risk | Hypotension, Sedation Risk |
---|---|---|---|---|---|---|---|
Partial mu receptor agonist-kappa receptor antagonist | Buprenorphine-naloxone | +++ | + | ++ | ++ | + | + |
Full mu receptor agonist | Methadone | +++ | ++ | +++ | +++ | ++ | + |
Alpha-2 adrenergic agonist | Clonidine, Lofexidine | ++ | +++ | + | + | + | +++ |
Note: + indicates relative magnitude on a scale from + to +++.